In vitro metabolic trends were assessed for 100 genotoxic agents detected i n two bacterial test systems, i .e., the Ames reversion test and a liquid DNA-repair test in Escherichia coli. Seventy-five compounds were found to undergo a more or less pronounced decrease'of genotoxicity, in at least one of these models, in the presence of rat liver homogenates or in other metabolic systems (up to 40 different preparations, from various sources, for chromium compounds). A number of these deactivable compounds are reported in the literature to yield negative or equivocal results in animal carcinogenicity assays, which may imply the existence of metabolically regulated thresholds in the initiation of cancer. Several examples are provided to support this hypothesis.
INTRODUCTION
The efficiency and the balance of metabolic pathways leading to activation or deactivation of xenobiotics can affect the carcinogenic potential of chemical compounds. Work carried out in this laboratory (1, 2) has provided evidence that a number of mutagens reported as negative or borderline or uncertain in animal carcinogenicity tests show a trend to decreased activity in the presence of metabolic systems. Therefore, they should not be considered as "false positives" in short-term models, but rather as potential carcinogens the effects of which in the organism can be prevented by detoxification mechanisms. Similar indications emerged from other studies, also with some nongenotoxic carcinogens (3, 4) .
This paper provides further evidence and additional examples of genotoxic compounds-using two bacterial test systems having a different genetic end point (a reversion test and a DNA-repair test)-the metabolic behavior of which can possibly explain their lack of carcinogenicity or the equivocal results obtained in animal assays. These data may imply the existence of metabolically regulated thresholds in the initiation of cancer. The possibility of potentiating detoxification mechanisms by means of pharmacologic agents is also envisaged.
METHODS

C h e rn ica I s
The 75 chemicals listed in Table I were either commerically available as reagent grade pure compounds or were a kind gift from colleagues. We refer to other papers (2, 5, 6 ) for detailed information on their source.
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DE FLORA
ToxfcoLocIc PATHOLOGY (7) using 7 his-Salmonella typhirnuriurn strains (TA1535, TA1537, TA1538, TA97, TA98, TA100, and TA102).
Bacterial DNA-repair Test The genotoxicity of test compounds was assessed by testing their differential lethality in Escherichia coli WP2 (repair-proficient strain) and in two repair-deficient counterparts, i.e., WP67 (uvrA-polA-) and CM871 (uvrA-recA-led-1. A liquid micromethod, calibrated in its technical details and validated with 135 compounds of various chemical classes (6), was used to evaluate the minimal inhibitory concentration (MIC) of test compounds in repair-proficient (rep+) and -deficient (rep-) bacteria and hence to calculate their genotoxic potency (see Footnote d to Table 11 ).
RESULTS A N D DISCUSSION
Metabolic Deactivation of Genotoxic Compounds as Related to Their Carcinogenic Properties
Of 100 genotoxic compounds of various chemical classes identified in this laboratory using the Ames reversion test and the DNArepair test in E. coli, 75 showed a direct activity which was decreased, in at least one of these in vitro models, in the presence of S-9 mixture containing liver S-9 fractions from Aroclor-treated rats ( Table I) . A large propor-tion of compounds investigated for carcinogenicity and showing this metabolic trend (18/47, i.e., 38.3%) are reported in the literature to be negative or uncertain in animal assays. Table 11 , summarizing potency data and the effect of S-9 mixture on 25 noncarcinogenic genotoxic compounds, provides further information supporting the importance of metabolic factors in explaining the discrepancy between the results of in vitro and in vivo assays. In fact, 40% of the noncarcinogenic compounds eliciting a mutagenic response in S . typhirnuriurn and as much as 95% of those inducing a nonreparable DNA damage in repair-deficient E. coli undergo a partial or complete loss of genotoxicity in the presence of liver homogenates.
Certainly, there are also other factors which may account for the lack of activity of bacterial genotoxins in whole organisms (8), and additionally S-9 fractions cannot thoroughly reproduce the complex metabolic competence and balance of intact cells. However, at least from a qualitative standpoint, a trend to metabolic deactivation suggests that a compound is expected to interact with DNA only if it penetrates target cells in amounts exceeding the specific detoxification mechanisms. This implies the existence of thresholds in the initiation of cancer, which are regulated by metabolic processes and hence are quantitatively affected by the multitude of genetic or environmental factors influencing the metabolism of xenobiotics (9) .
Examples of Deactivable Genotoxic Compounds Yielding Negative or Equivocal Results in Carcinogenicity Assays
The existence of a threshold may either totally prevent the potential Carcinogenicity of a genotoxic compound or result in particular dose-response effects, for instance in the induction of tumors only close to the maximum tolerated doses suggested in guidelines for carcinogenicity assays, which are justified by technical reasons but generally are not representative of the actual human exposure load. Such situation may lead to inconsistencies between different animal experiments. An example, among the genotoxic agents undergoing metabolic deactivation (Table I) , may be represented by the structur-ally related pesticides captan and folpet. Both compounds were initially reported to be noncarcinogenic in mice (lo), while a more recent study with captan (11) showed its weak carcinogenicity in the same animal species and its inactivity in rats. Other compounds eliciting direct damage in E. coli DNA, which is eliminated in the presence of liver homogenates, are aniline and its urinary metabolites oand p-aminophenol, the carcinogenic properties of which are still under discussion (12) . A compound of special interest is the flavonoid quercitin, the only genotoxic agent exhibiting sharply contrasting metabolic trends in bacterial systems (increase of activity in the reversion test and complete deactivation in the DNA-repair test), as well as conflicting effects in animal carcinogenicity tests (13) .
The administration route is of great imporat SAGE PUBLICATIONS on December 9, 2012 tpx.sagepub.com Downloaded from Vol. 12, NO. 4, 1984 METABOLISM IN CARCINOGENICITY 341 tance in conditioning the carcinogenicity of deactivable genotoxic compounds. For instance, the antitumor compound ICR 170 induced lung adenomas in mice when administered i.v., but not following i.p. administration, a route which clearly involves a slower absorption and distribution prior to reaching the lungs. Interestingly, the structurally related ICR 191 (which is even more potent than ICR 170 in bacterial test systems) and ICR 191-OH, both noncarcinogenic when given i.v., are deactivated by S-9 fractions from the liver and other tissues of different animal species [rat, mouse, humans) more efficiently and more rapidly than ICR 170 (14) . Another example may be sodium azide, whose potent induction of base-pair substitutions in Salmonella DNA is decreased both by liver S-9 fractions and, with pH-dependent efficiency, by human gastric juice (15) . It is noteworth , in connection with these data, assessed in rats treated either orally or by gastric intubation (16) . A group of compounds undergoing metabolic deactivation is constituted by epoxides, whose detoxification pathways are well-documented (17) . As shown in Table I , their evidence of animal carcinogenicity is limited or inconclusive, and the only positive' epoxide among those examined in this laboratory (epichlorohydrin) was found to be carcinogenic, following different administration routes, only close to its application sites (12) .
We have been testing in vitro some compounds in the presence of up to 40 different metabolic systems (e.g., cell preparations and body fluids from different animal species, under the influence of various treatments, diets, or pathologic conditions). This approach might be useful to explain or to predict the target(s) of some carcinogens, especially of those interacting with DNA within the same cells where they are biotransformed. An example to this respect may be offered by studies performed with chromium compounds (18), the conclusions of which are consistent with the lack of carcinogenicity of this metal by the oral route or at distance from its administration site. Also in the lung, which is the only recognized target for chromium (although with quantitative uncertainties both in animal and epidemiologic studies), its capability of interacting with DNA appears to be limited by microsomal NADPHrequiring enzymes leading to reduction of Cr[VI) to Cr(II1) and to the subsequent trap-that the la E k of carcinogenicity of azide was ping of the former in the cytoplasm. Interestingly, such a threshold in chromium pulmonary carcinogenicity appears to be inducible in rodents not only by known enzyme stimulators but also by the repeated intratracheal administration of Cr(V1) itself (18) .
In Vitro Effects of a Drug (N-Acetylcysteine) on the Activity and Metabolism of Genotoxic Agents
It is well-recognized that intracellular glutathione (GSH) plays an important role as a threshold in reactive metabolite toxicity (19, 20) . Among the thiol compounds promoting GSH synthesis or replacing its functions, N-acetylcysteine (NAC) is of special interest, because it is already extensively used as a mucolytic drug in a population of individuals who may be more heavily exposed to cancer initiators and/or promoters. Additionally, NAC is very well tolerated and has been successfully used as an antidote against a variety of toxic agents (21) .
We have just concluded a study (22) aiming at investigating in vitro the effects of NAC on some biochemical parameters and on the mutagenicity of four direct-acting compounds and six procarcinogens. Five enzyme activities involved in GSH metabolism (glucose-6phosphate dehydrogenase, 6-phosphogluconate dehydrogenase, malic enzyme, GSH peroxidase, and oxidized glutathione (GSSG) reductase) were monitored under various conditions in the liver S-9 fractions from Aroclor-treated rats used in mutagenicity assays. The only effects detected in vitro were a stimulation of NAC on GSSG reductase (which is consistent with an enhanced rate of GSH formation) and a protection of this enzyme activity by NAC against oxidizing agents (sodium dichromate).
A short preincubation (30 min at 37°C) of NAC with dichromate and 4-nitroquinolino-N-oxide (4NQO) resulted in a dose-dependcnt decrease and, in excess of NAC, in a complete elimination of their mutagenicity in the Ames test. This could be ascribed to chemical reduction in the case of the Cr(V1) compound and to trapping of molecules in the case of4NQO. Although to a lesser extent, NAC also decreased the mutagenicity of epichlorohydrin and of hydrogen peroxide. The latter compound reverts strain TA102 of S. typhimurium, which is sensitive to oxidizing agents (23, 24) . Additionally, high doses of NAC completely eliminated the S-9-requiring mutagenicity of cyclophosphamide, 2- aminofluorene (ZAF), cigarette smoke condensate, aflatoxin B, (AFBI), and benzo-(a)pyrene, and decreased the mutagenicity of a tryptophan pyrolysate. Inhibition of mutagenicity by NAC was not dependent on metabolic factors but on trapping of the mutagenic metabolites of these procarcinogens. On the other hand, intermediate doses of NAC resulted in a potentiation of the metabolic activation of some of the above compounds, a phenomenon which had been unexpectedly observed in vitro also by combining GSH with AFBl and polycyclic aromatic hydrocarbons in the Ames test (25) (26) (27) . However, more recent experiments performed in this laboratory, using the DNA-repair test in E. coli, do not confirm this effect, and provide evidence for a dose-related decrease of genotoxicity of AFBl and 2AF, in the presence of S-9 mixture, following combination with varying amounts of NAC (Table HI) . Table 111 also shows the sharp decrease of genotoxic potency observed, also in the DNA-repair test, by mixing NAC with the direct-acting DNA-damaging agent hydrogen peroxide. The case of this compound generating oxygen radicals (23) is of interest, because GSH is also known to play a major role in detoxifying the cell from peroxides and free radicals (20) .
